Rate of change in salivary amylase pre- and post-VR operation. by Akihiro Kakimoto (343218)

Subjects:

Difference in by Akihiro Kakimoto (343218)

Subjects:

Relationship between the change in by Akihiro Kakimoto (343218)

Subjects:

Increase in multiple-choice question scores pre- and post-VR operation. by Akihiro Kakimoto (343218)

Subjects:

Multiple-choice questions and performance pre- and post-VR operation. by Akihiro Kakimoto (343218)

Subjects:

Average scores of TDMS-ST pre- and post-VR operation. by Akihiro Kakimoto (343218)

Subjects:

VR training system for radiopharmaceutical administration. by Akihiro Kakimoto (343218)

Subjects:

Experimental protocol. by Akihiro Kakimoto (343218)

Subjects:

Average scores of POMS2 pre- and post-VR operation. by Akihiro Kakimoto (343218)

Subjects:

Opioid consumption data. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). …”

Prescription data. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). …”

Refill rate by surgical specialty. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). …”

Noncontinuous data on opioid use. by Wali U. Pirzada (22278071)

“…Mean percent reduction in prescription size was greater in the Orthopaedic Surgery cohort (45% versus 38%) (p = .002). …”

Definitions of variables. by Qi Zhang (28502)

Subjects:

Theoretical model diagram. by Qi Zhang (28502)

Subjects:

PSM and Heckman regression results. by Qi Zhang (28502)

Subjects:

Regression results from a business risk perspective. by Qi Zhang (28502)

Subjects:

Other robustness test regression results. by Qi Zhang (28502)

Subjects:

Baseline regression results. by Qi Zhang (28502)

Subjects:

Univariate analysis results. by Qi Zhang (28502)

Subjects: